Consensus on fecal microbiota transplantation research
Fecal microbiota transplantation (FMT) is a highly effective approach in treating recurrent Clostridioides difficile infections (CDI). Beyond CDI, it is also potentially beneficial in other microbiota-related disorders. The study “Scientific frontiers in fecal microbiota transplantation: joint document of Asia-Pacific Association of Gastroenterology (APAGE) and Asia-Pacific Society for Digestive Endoscopy (APSDE)” has summarized the consensus of 16 experts on key issue in FMT research in a frontiers meeting. Since FMT is not a one-size-fits-all strategy, it requires optimization before its therapeutic promise can be evaluated for different diseases. Therefore, studies are required to identify microbial components microbiota that have specific effects in patients with different diseases. (Gut. 2020 Jan;69(1):83-91. doi: 10.1136/gutjnl-2019-319407. Epub 2019 Oct 14.)
Anyone interested in future collaboration in this field of research is welcome to contact our key investigator Prof Siew C. Ng in the Department of Medicine & Therapeutics, CUHK. Prof Ng’s research interests are epidemiology, genetics, pathogenesis, and treatment of IBD, role of Gut microbiota in health and disease and fecal microbiota transplantation and microbial therapeutics.
Read full article: https://gut.bmj.com/content/69/1/83.full